Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 25, 2018 - Synergy Pharmaceuticals announced the FDA approval of Trulance (plecanatide) for the treatment of adults with irritable bowel syndrome with constipation (IBS-C).
Return to publications